Mango Materials Champions Opportunity For 'Naturally Occurring Biopolymer' Use

The US Microbead-Free Waters Act bans use of plastic microbeads in rinse-off exfoliating or cleansing cosmetics, but Mango Materials’ “naturally occurring biopolymer” isn’t plastic by most standards. Regardless, it can be used in other cosmetic product categories and as an alternative to conventional plastic packaging, so long as future regulation in the US and abroad doesn’t needlessly prohibit the material’s use, the company says.

Bottles-Microbeads-Alert-illustration_1200x675

Mango Materials is working to secure a place for its biodegradable polyhydroxybutyrate (PHB) in next-generation plastic applications around the globe, even if the door has partly closed on the material’s use in the US personal-care sector under the federal Microbead-Free Waters Act.

That legislation, enacted in December 2015, gives industry until July 1, 2017, to stop producing rinse-off cosmetics containing plastic microbeads...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

Non-US Approvals - Clone

Devices authorized for marketing outside the US. Data derived from Citeline’s Meddevicetracker. Updated weekly.

Patient access to unapproved medical products allowed under DeFazio, Daschle bills.

 
• By 

PATIENT ACCESS TO UNAPPROVED MEDICAL PRODUCTS WOULD BE ALLOWED under legislation introduced by Rep. Peter DeFazio (D-Ore.) on July 12 and Sen. Tom Daschle (D-S.D.) on July 14. Called the Access to Medical Treatment Act, the legislation would allow health practitioners to administer unapproved drugs, devices, foods or dietary supplements to patients as long as there is no evidence the treatment causes harm and the patient is informed about the treatment and its possible side effects. DeFazio's bill is identified as HR 2019; Daschle's version will be assigned a bill number the week of July 17.

ADHD Medications and Cardiovascular Effects: New Data Revealed. (A Comprehensive Evaluation of Emerging Clinical and Epidemiological Evidence on the Cardiovascular Effects Associated with Commonly Prescribed Medications for Attention Deficit Hyperactivity Disorder)

 
• By 

A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.

More from HBW Insight

data

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

headline test

description